Clear Point Advisors’s Merck MRK Stock Holding History

Clear Point Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-300	Closed	-$34.1K	–	375
2024 Q3	$34.1K	Hold	300	–	–	0.03%	233
2024 Q2	$37.2K	Hold	300	–	–	0.03%	216
2024 Q1	$39.6K	Hold	300	–	–	0.03%	220
2023 Q4	$32.7K	Buy	+300	New	+$31.1K	0.03%	222

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clear Point Advisors's MRK Position: Q4 2024 in Review

Clear Point Advisors sold out of Merck (MRK) in Q4 2024, closing a stake of 300 shares — an estimated $34.1K sold.

Clear Point Advisors first reported a position in MRK in Q4 2023 and held it in 4 quarters. The position peaked at $39.6K in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

Clear Point Advisors reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
Clear Point Advisors sold 300 Merck shares in Q4 2024, an estimated $34.1K.
Clear Point Advisors first reported a position in Merck in Q4 2023 and held it in 4 quarters.
Clear Point Advisors's Merck position peaked at $39.6K in Q1 2024.
3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Clear Point Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.